廣州:本輪疫情爲奧密克戎變異株感染 已排查密接次密接千餘人
格隆匯2月16日丨據央視,在廣州市疫情防控新聞發佈會上,廣州市衛生健康委副主任陳斌介紹,本輪疫情2名病例病毒基因分型爲奧密克戎變異株。目前,廣州已甄別密切接觸者617人,次密接520人,已全部採集核酸,已出結果全部陰性,並全部納入管理。截止到16日14時,已完成黃碼核酸檢測65908人,結果全部爲陰性。本輪疫情重點人羣384人已落實賦“黃碼”,54份新採集環境樣本均爲陰性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.